Nemes Rush Group’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $43.1K | Hold |
2,000
| – | – | ﹤0.01% | 345 |
|
|
2025
Q1 | $33.2K | Hold |
2,000
| – | – | ﹤0.01% | 357 |
|
|
2024
Q4 | $36.7K | Hold |
2,000
| – | – | ﹤0.01% | 338 |
|
|
2024
Q3 | $37K | Hold |
2,000
| – | – | 0.01% | 293 |
|
|
2024
Q2 | $32.5K | Hold |
2,000
| – | – | ﹤0.01% | 302 |
|
|
2024
Q1 | $37K | Hold |
2,000
| – | – | 0.01% | 318 |
|
|
2023
Q4 | $62.6K | Hold |
2,000
| – | – | 0.01% | 242 |
|
|
2023
Q3 | $41.7K | Hold |
2,000
| – | – | 0.01% | 272 |
|
|
2023
Q2 | $47.9K | Buy |
+2,000
| New | +$47.9K | 0.01% | 268 |
|